Business Wire

THALES

8.10.2019 12:59:03 CEST | Business Wire | Press release

Share
Thales Study: Organizations Worldwide Failing to Adequately Protect Sensitive Data in the Cloud

A new global study from Thales , with research from the Ponemon Institute, has exposed an increasing disparity between the rapid growth of data stored in the cloud and an organization’s approach to cloud security. Although nearly half (48%) of corporate data is stored in the cloud, only a third (32%) of organizations admit they employ a security-first approach to data storage in the cloud.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191008005492/en/

Surveying over 3,000 IT and IT security practitioners in Australia, Brazil, France, Germany, India Japan, the United Kingdom and the United States, the research found that only one in three (31%) organizations believe that protecting data in the cloud is their own responsibility.

Increased multi-cloud cloud use, but with risks

With the proliferation of cloud-based services, businesses and other organizations are increasingly dependent on cloud providers. In fact, nearly half (48%) of organizations have a multi-cloud strategy, with Amazon Web Services (AWS), Microsoft Azure and IBM being the top three. The study found that, on average, organizations use three different cloud service providers and over a quarter (28%) are using four or more.

Despite storing sensitive data in the cloud, nearly half (46%) surveyed revealed that storing consumer data in the cloud makes them more of a security risk. Over half (56%) also noted that it posed a compliance risk. In addition, organizations believe that cloud service providers bear the most responsibility for sensitive data in the cloud (35%), ahead of shared responsibility (33%) and themselves (31%). Even though businesses are pushing the responsibility to cloud providers, only 23% say security is a factor in selecting them.

“With businesses increasingly looking to use multiple cloud platforms and providers, it’s vital they understand what data is being stored and where,” said Larry Ponemon, chairman and founder of the Ponemon Institute. “Not knowing this information makes it essentially impossible to protect the most sensitive data --ultimately leaving these organizations at risk. We’d encourage all companies to take responsibility for understanding where their data sits to ensure it’s safe and secure.”

Encryption increasing, but organizations handing over keys to cloud providers

Roughly half (51%) of businesses and other organizations still do not use encryption or tokenization to protect sensitive data in the cloud. The study uncovered regional disparities in terms of data security, with German organizations being the most advanced in their use of encryption at 66%.

Organizations are handing over the keys to their encrypted data to cloud providers. Nearly half of cloud companies (44%) provide the encryption keys when data is encrypted in the cloud, ahead of in-house teams (36%) and third parties (19%). On top of this, 53% are controlling these encryption keys themselves, despite 78% saying it’s important their organization retains control of the keys.

Over half of businesses (54%) think cloud storage makes it more difficult to protect sensitive data, up from 49% last year. More than 70% believe that data in a cloud environment is harder to protect due to the complexity of managing privacy and data protection regulations, while an additional two-thirds (67%) cited the difficulty of applying conventional security methods in the cloud.

“This study shows that businesses today are taking advantage of the opportunities that new cloud options offer, but aren’t adequately addressing data security,” said Tina Stewart, vice president of market strategy for cloud protection and licensing activity at Thales . “Having pushed the responsibility towards cloud providers, it is surprising to see that security is not a primary factor during the selection process. It doesn’t matter what model or provider you choose, the security of your business’ data in the cloud has to be your responsibility. Your organization’s reputation is on the line when a data breach occurs, so it is critical to ensure in-house teams keep a close eye on your security posture and always retain control of encryption keys.”

For more information, attend our “Global Trends in Cloud Security: Gaps in Security Persist in a Multi-Cloud World” webinar taking place on November 7 or visit the 2019 Thales Cloud Security Study website .

Research methodology

This research was conducted by the Ponemon Institute on behalf of Thales with 3,667 IT and IT security practitioners surveyed across the Australia, Brazil, France, Germany, India, Japan, the United Kingdom and the United States.

Industry insight and views on the latest data security trends can be found on the Thales blog at blog.thalesesecurity.com .

Follow Thales on Twitter , LinkedIn , Facebook and YouTube .

About Thales

Thales (Euronext Paris: HO) is a global technology leader shaping the world of tomorrow today. The Group provides solutions, services and products to customers in the aeronautics, space, transport, digital identity and security, and defence markets. With 80,000 employees in 68 countries, Thales generated sales of €19 billion in 2018 (on a pro forma basis including Gemalto).

Thales is investing in particular in digital innovations — connectivity, Big Data, artificial intelligence and cybersecurity — technologies that support businesses, organisations and governments in their decisive moments

PLEASE VISIT
Thales Group
Security
Download HD photos

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

IEO and Laife Reply Join Forces to Digitalise the Biobank Through Artificial Intelligence10.2.2026 10:00:00 CET | Press release

The two partners launch “Bianca”, the first large-scale digitalisation initiative in Italy focused on histopathological samples, aimed at training AI algorithms to support pathologists’ diagnostic activities. The Pathology Division of the European Institute of Oncology (IEO) and Laife Reply, the Reply Group company specialised in AI and Big Data solutions for the healthcare sector, have entered into a collaboration to develop Bianca, the first project in Italy aimed at creating an AI-based digital biobank designed as an integral part of clinical diagnostic practice. The initiative is part of a broader technological innovation journey that structurally integrates research and development into routine diagnostic processes in pathology, transforming the traditional histopathological sample workflow into an end-to-end digital ecosystem. The complete digitalisation of histopathological and molecular diagnostic workflows aims to make analysis more efficient, scalable and reproducible, laying

OPEX® Corporation Introduces the Velo™ Series of Premium Desktop and High Production Document Scanners10.2.2026 10:00:00 CET | Press release

OPEX® Corporation, a global leader in Next Generation Automation providing innovative solutions for warehouse, document and mail automation, has announced the launch of its Velo™ Series powered by InoTec, a new class of premium desktop and free standing high production scanners. The OPEX Velo scanners are engineered to deliver exceptional performance, reliability and image quality and offer industry-standard TWAIN/ISIS connectivity to help simplify deployment into existing capture environments. These state-of-the-art scanners are ideal for service bureaus, government agencies, healthcare providers and enterprise capture operations. “The Velo Series powered by InoTec introduces an entirely new class of scanners to the OPEX portfolio, expanding the options available to both our current customers and organizations considering OPEX for the first time,” said Dann Worrell, President, Document and Mail Automation, OPEX. “By broadening our offerings, we can better align the right solution with

New ZOLL Zenix Monitor/Defibrillator Receives MDR Approval10.2.2026 10:00:00 CET | Press release

ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that Zenix®, the company’s most clinically advanced and easy-to-use professional monitor/defibrillator, is approved under the European Union (EU) Medical Device Regulation 2017/745, commonly referred to as EU MDR. The Zenix monitor/defibrillator is a groundbreaking device that redefines efficiency, clarity, and intelligence in both EMS and hospital settings. Built from years of feedback from customers, Zenix combines intuitive design with powerful functionality to enhance patient care and automate workflows for ease-of-use. Featuring a large, durable touchscreen, Zenix provides critical information when it’s needed. With on-the-fly customization, healthcare professionals can make real-time adjustments, helping them stay in control during high-pressure situations. Equipped with ZOLL’s innovative Real BVM Help® and exclusive Real CPR Help® technology, Zenix gives healthcare pro

Expereo Elevates expereoOne with New Digital Case Management Capabilities, Delivering Faster, Clearer and More Predictable Service Resolution10.2.2026 10:00:00 CET | Press release

Expereo is redefining what’s possible for global enterprises at CiscoLive Amsterdam with the launch of its enhanced Digital Case Management (DCM) capability in expereoOne. As the world-leading managed Network as a Service (NaaS) provider, Expereo is putting customers firmly in control - slashing resolution times, cutting through operational noise and ensuring everyone is aligned every step of the way. With DCM, service issues are no longer bottlenecks: instead, enterprises experience swift, transparent outcomes, with every stakeholder empowered through a single, real-time view of progress. DCM is designed around a simple objective: enable enterprises to resolve issues faster, with greater clarity and full control, through a fully digital, software-first workflow inside expereoOne. Customers can create, manage and track cases end-to-end within a single platform, ensuring predictable, consistent and aligned service experiences across their global network footprint. Unified, digital-first

U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 110.2.2026 09:15:00 CET | Press release

This FDA Acceptance is a Milestone for People Living with Narcolepsy Type 1 Who Need New and Different Treatment OptionsOveporexton is an Orexin Agonist Designed to Restore Orexin Signaling and Address the Underlying Orexin Deficiency that Causes Narcolepsy Type 1The Prescription Drug User Fee Act (PDUFA) Target Action Date is the Third Quarter of this Calendar Year Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) and granted Priority Review for oveporexton (TAK-861) for the treatment of narcolepsy type 1 (NT1). Oveporexton is an investigational oral orexin receptor 2 (OX2R)-selective agonist designed to address the underlying orexin deficiency that causes NT1 by restoring orexin signaling. The FDA has set a Prescription Drug User Fee Act (PDUFA) goal date in the third quarter of this calendar year. Takeda remains on track to potentially bring the first approved orexin agonist treatment to people living

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye